HIV Blood Test | SINGAPORE SEXUALHEALTH™
HIV Blood Test | SINGAPORE SEXUALHEALTH™ @singaporesexualhealth_com: HIV (human immunodeficiency virus) blood test, Singapore. Private & confidential service.
Come to sunny Singapore to have your testing and treatment. Singapore Ministry of Health registered general practice (GP) clinic:
| SHIM CLINIC|
168 Bedok South Avenue 3 #01-473
Tel: (+65) 6446 7446
Fax: (+65) 6449 7446
24hr Answering Tel: (+65) 6333 5550
Web: HIV Blood Test | SINGAPORE SEXUALHEALTH™
| Opening Hours |
Monday to Friday: 9 am to 3 pm, 7 pm to 11 pm
Saturday & Sunday: 7 pm to 11 pm
Public Holidays: Closed
Last registration: one hour before closing time.
Walk-in clinic. Appointments not required.
Bring NRIC, Work Pass or Passport for registration.
Table of Contents HIV Test / HIV Testing / HIV Check / HIV Checking / HIV Screen / HIV Screening
HIV is the abbreviation for the human immunodeficiency virus, which causes the acquired immunodeficiency syndrome
HIV symptoms which may present in acute HIV infection: These are nonspecific symptoms and can present with other infections; consequently, they are unreliable indicators of HIV infection.
Remember, there is no HIV cure.
HIV window period is the time from HIV infection until a HIV Test can detect any change. Within the HIV window period, the HIV Test would be negative. During this period, the HIV viral load is extremely high, thus making the person highly infectious.
References HIV ELISA (Enzyme-linked immunosorbent assay) test generations:
- 4 weeks after exposure, a negative 4th generation HIV ELISA Test "is very reassuring / highly likely to exclude HIV infection."
- 12 weeks after exposure, a negative 3rd generation HIV ELISA Test "would definitively exclude HIV infection."
References HIV rapid test (20 minutes to results) Two types are available:
- 1st generation: HIV-1 IgG antibody
- 2nd generation: HIV-1 & HIV-2 IgG antibodies
- 3rd generation: HIV-1 & HIV-2 IgG & IgM antibodies
- 4th generation: HIV-1 & HIV-2 IgG & IgM antibodies and HIV p24 antigen
Note: If the clinic attendance is only for the HIV rapid test, then consultation fees are not added.
References HIV PCR (polymerase chain reaction) NAT (nucleic acid test) HIV Risk (2009 figures)
Estimated HIV transmission risk per exposure for specific activities and events
|Activity ||Risk-per-exposure |
|Vaginal sex, female-to-male, studies in high-income countries ||0.04% (1:2380) |
|Vaginal sex, male-to-female, studies in high-income countries ||0.08% (1:1234) |
|Vaginal sex, female-to-male, studies in low-income countries ||0.38% (1:263) |
|Vaginal sex, male-to-female, studies in low-income countries ||0.30% (1:333) |
|Vaginal sex, source partner is asymptomatic ||0.07% (1:1428) |
|Vaginal sex, source partner has late-stage disease ||0.55% (1:180) |
|Receptive anal sex amongst gay men, partner unknown status ||0.27% (1:370) |
|Receptive anal sex amongst gay men, partner HIV positive ||0.82% (1:123) |
|Receptive anal sex with condom, gay men, partner unknown status ||0.18% (1:555) |
|Insertive anal sex, gay men, partner unknown status ||0.06% (1:1666) |
|Insertive anal sex with condom, gay men, partner unknown status ||0.04% (1:2500) |
|Receptive fellatio ||Estimates range from 0.00% to 0.04% (1:2500) |
|Mother-to-child, mother takes at least two weeks antiretroviral therapy ||0.8% (1:125) |
|Mother-to-child, mother takes combination therapy, viral load below 50 ||0.1% (1:1000) |
|Injecting drug use ||Estimates range from 0.63% (1:158) to 2.4% (1:41) |
|Needlestick injury, no other risk factors ||0.13% (1:769) |
|Blood transfusion with contaminated blood ||92.5% (9:10) |
Sources: vaginal sex;1 anal sex;2 fellatio;3 2 mother-to-child;4 other activities.5
- Boily MC et al. Heterosexual risk of HIV-1 infection per sexual act: systematic review and meta-analysis of observational studies. Lancet Infect Dis 9(2): 118-129, 2009
- Vittinghoff E et al. Per-contact risk of human immunodeficiency virus transmission between male sexual partners. American Journal of Epidemiology 150: 306-311, 1999
- Del Romero J et al. Evaluating the risk of HIV transmission through unprotected orogenital sex. AIDS 16(9): 1296-1297, 2002
- Townsend C et al. Low rates of mother-to-child transmission of HIV following effective pregnancy interventions in the United Kingdom and Ireland, 2000-2006. AIDS 22: 973-981, 2008
- Baggaley RF et al. Risk of HIV-1 transmission for parenteral exposure and blood transfusion. AIDS 20: 805-812, 2006
- HIV & AIDS Information :: How transmission occurs - Estimated risk per exposure
HIV Risk (2005 figures)
Estimated per-act risk for acquisition of HIV, by exposure route*
*Estimates of risk for transmission from sexual exposures assume no condom use.
|Exposure route||Risk per 10,000|
to an infected source
|Needle-sharing injection-drug use||67||0.67|
|Receptive anal intercourse||50||0.5|
|Percutaneous needle stick||30||0.3|
|Receptive penile-vaginal intercourse||10||0.1|
|Insertive anal intercourse||6.5||0.065|
|Insertive penile-vaginal intercourse||5||0.05|
|Receptive oral intercourse†||1||0.01|
|Insertive oral intercourse†||0.5||0.005|
†Source refers to oral intercourse performed on a man.
HIV risk (2002 figures)
HIV Risk Statistics (chances of getting HIV)
|HIV Risk Factors ||HIV Transmission Probability |
|Needle stick injury3 ||1/300 |
|Receptive anal intercourse4 ||1/100 |
|Receptive vaginal intercourse5 ||1/1000 |
|Insertive vaginal intercourse4 ||1/2000 |
|Insertive anal intercourse4 ||1/2500 |
|Receptive fellatio with ejaculation4 ||1/2500 |
|Sharing needles6 ||1/150 |
HIV prevention / HIV PEP (post-exposure prophylaxis) treatment can prevent you from getting an HIV infection, and turning HIV positive.
- Cardo DM, Culver DH, Ciesielski CA, et al. A Case-Control Study of HIV Seroconversion in Health Care Workers after Percutaneous Exposure. N Engl J Med. 1997;337:1485-1490.
- Katz MH, Gerberding JL. Management of occupational and nonoccupational postexposure HIV prophylaxis. Current Inf Dis Reports. 2002;4:543-549.
- Gerberding JL. Prophylaxis for Occupational Exposure to HIV. Ann Intern Med. 1996;6:497-501
- Vitinghoff E, Douglas J, Judon F, et al. Per-Contact Risk of Human Immunodificiency Virus Transmision between Male Sexual Partners. Am J Epidemiol. 1999;150:306-311.
- Peterman TA, Stoneburner RL, Allen JR, et al. Risk of Human Immunodeficiency Virus Transmission From Heterosexual Adults With Transfusion-Associated Infections. JAMA. 1988;259:55-58. [Erratum. JAMA. 1989;262:502]
- Kaplan EH, Heimer R. A Model-Based Estimate of HIV Infectivity via Needle Sharing. J Acquir Immune Defic Syndr. 1992;5:1116-1118.
Individuals are eligible for HIV PEP Treatment if all the following criteria are met:
Prompt antiviral therapy may reduce the risk of HIV transmission by as much as 80%.
- less than 72 hours has elapsed since exposure;
- the exposed individual is not known to be HIV infected;
- the person who is the source of exposure is HIV infected or has unknown HIV status;
- mucous membrane or non-intact skin was exposed to a potentially infectious body fluid;
For optimal efficacy, antiretroviral therapy should be started as soon as possible, ideally within 1 hour of exposure. So that you can remain HIV negative.
The medications and dosages are the same as those used for lifelong treatment of HIV patients. However, for HIV PEP treatment, it is taken for only a month.
References Drugs commonly used in HIV PEP: References TORCH
(of HIV/STD/pregnancy), and what you can do before and after exposure.
Efficacy and safety in clinical practice of a rilpivirine, tenofovir and emtricitabine single-tablet regimen in virologically suppressed HIV-positive patients on stable antiretroviral therapy.
Tue, 04 Aug 2015 06:18:04 +0100 | Journal of the International AIDS Society
CONCLUSIONS: The study findings confirm the efficacy and safety in clinical practice of switching to RTE STR in virologically suppressed patients receiving other antiretrovirals.
Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202
Mon, 03 Aug 2015 22:45:19 +0100 | Pharmacogenetics and Genomics
Conclusion: Among patients randomized to receive TDF/emtricitabine in A5202, there were no significant genomewide associations with change in CrCl. This study did not replicate polymorphisms previously implicated in tenofovir-associated renal injury. (Source: Pharmacogenetics and Genomics)
Does focal incidental 18 F-FDG PET/CT uptake in the prostate have significance?
Mon, 03 Aug 2015 19:01:53 +0100 | Abdominal Imaging
Swaziland: False Claim of Obama Support for King
Mon, 03 Aug 2015 13:20:18 +0100 | AllAfrica News: HIV-Aids and STDs
[Swazi Media] The Swazi Observer, a newspaper in effect owned by King Mswati III, has falsely claimed the US President Barack Obama 'is fully behind' and 'endorses' the King's pledge to personally rid Swaziland of AIDS. (Source: AllAfrica News: HIV-Aids and STDs)
Rwanda: Breastfeeding Week - Ray of Hope for Mothers With HIV
Mon, 03 Aug 2015 12:09:50 +0100 | AllAfrica News: HIV-Aids and STDs
[New Times] During the first six months of a child's life, breastfeeding is considered the most ideal meal for a baby. This is because breast milk contains vital nutrients such as vitamins, proteins, carbohydrates and minerals among others that are necessary for proper growth and development. Besides these nutrients, a breastfeeding baby receives antibodies from the mother as a form of natural immmunity to fend off microorganisms. (Source: AllAfrica News: HIV-Aids and STDs)
Ethiopia: Efforts to Promote Safe Motherhood, Arrest HIV, Aids
Mon, 03 Aug 2015 12:04:11 +0100 | AllAfrica News: HIV-Aids and STDs
[Ethiopian Herald] Taking medical examination during pregnancy absolutely helps come up with healthy motherhood (Source: AllAfrica News: HIV-Aids and STDs)
Kenya: Scientists Back Use of New Drug to Prevent HIV in Discordant Couples
Mon, 03 Aug 2015 10:42:14 +0100 | AllAfrica News: HIV-Aids and STDs
[Nation] Scientists have backed the use of an anti-retroviral drug before sex to prevent HIV infection among couples where one partner is not infected. (Source: AllAfrica News: HIV-Aids and STDs)
East Africa: HIV Testing in Infants to Cost Less Across the Globe
Mon, 03 Aug 2015 10:23:17 +0100 | AllAfrica News: HIV-Aids and STDs
[East African] Global partners in the HIV/Aids Diagnostics Access Initiative have announced a 35 per cent reduction in the price for early infant diagnostic technologies. (Source: AllAfrica News: HIV-Aids and STDs)
Zambia: 11,000 Access ARVs in Mongu
Mon, 03 Aug 2015 10:00:35 +0100 | AllAfrica News: HIV-Aids and STDs
[Times of Zambia] Mongu District Commissioner Susiku Kamona said a total of 10,986 adults and 617 children have been enrolled for Anti-Retroviral Therapy (ART). (Source: AllAfrica News: HIV-Aids and STDs)
Malawi: Malawians Taking Painkillers to Have HIV Test Results Compromised
Mon, 03 Aug 2015 08:55:11 +0100 | AllAfrica News: HIV-Aids and STDs
[Malawi24] A new trend has come upon Malawians who are busy swallowing pain killers before going for HIV test and drinking cocacola with the hope that it will interfere with their HIV results, Malawi24 can reveal. (Source: AllAfrica News: HIV-Aids and STDs)